From Diagnosis to Destruction: The Rise of Radioligand Therapeutics as Oncology's New Pillar.

Annals of Oncology · 25 Oct 2026 · Editorial · Open access

Herrmann

The abstract is read at the publisher; the summary is JClub's.

There's no AI summary of this paper here yet.

Open access

Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.

Bismuth Quadruple Therapy as an Unstable Benchmark for Noninferiority.
Gastroenterology · 1 Nov 2026 · Letter
Read it in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42476322
Open in JClub
Cancer theranostics.
Nature Reviews Cancer · 22 Oct 2026 · Review
AI summary · may contain errors
Theranostics in oncology integrates diagnostic imaging and radionuclide therapy using matched probes, and clinical progress is linked to a promising future for multiscale approaches.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42918868
Open in JClub

Journals this month

All journals →

Topics moving, week to 13 Nov 2026

All topics →

By field

All journals by field →

From Diagnosis to Destruction: The Rise of Radioligand Therapeutics as Oncology's New Pillar.

Related in JClub

Bismuth Quadruple Therapy as an Unstable Benchmark for Noninferiority.

Cancer theranostics.

Browse JClub